GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.

Article  Google Scholar 

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544.

Article  Google Scholar 

Forner A, Reig M, Bruix J. Hepatocellular carcinoma. The Lancet. 2018;391:1301–14.

Article  Google Scholar 

Chinese Society of Infectious Diseases, Chinese Medical Association. Chinese Society of Hepatology, Chinese Medical Association [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. Zhonghua Gan Zang Bing Za Zhi. 2019;27:938–61.

Google Scholar 

Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384–91.

Article  PubMed  Google Scholar 

Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223–38.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Sharma SA, Kowgier M, Hansen BE, et al. Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis. J Hepatol. 2018;68:92–9.

Article  Google Scholar 

Chen XP, Wu ZD, Huang ZY, et al. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg. 2005;92:334–9.

Article  PubMed  Google Scholar 

Bai DS, Qian JJ, Chen P, et al. Modified laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension. Surg Endosc. 2014;28:257–64.

Article  PubMed  Google Scholar 

Jiang GQ, Bai DS, Chen P, et al. Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion. World J Gastroenterol. 2014;20:18420–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388–414.

Article  PubMed  PubMed Central  Google Scholar 

Bai DS, Zhou BH, Qian JJ, et al. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study. Surg Endosc. 2020;34:5074–82.

Article  PubMed  Google Scholar 

Yu H, Guo S, Wang L, et al. Laparoscopic splenectomy and esophagogastric devascularization for liver cirrhosis and portal hypertension is a safe, effective, and minimally invasive operation. J Laparoendosc Adv Surg Tech A. 2016;26:524–30.

Article  PubMed  Google Scholar 

Zhe C, Jian-wei L, Jian C, et al. Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: a comparative study. J Gastrointest Surg. 2013;17:654–9.

Article  PubMed  Google Scholar 

Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47(Suppl):S2-6.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, El-Serag HB, Thrift AP. Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev. 2020;29:88–94.

Article  PubMed  Google Scholar 

Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104–7.

Article  CAS  PubMed  Google Scholar 

Murata K, Shiraki K, Sugimoto K, et al. Splenectomy enhances liver regeneration through tumor necrosis factor (TNF)-alpha following dimethylnitrosamine-induced cirrhotic rat model. Hepatogastroenterology. 2001;48:1022–7.

CAS  PubMed  Google Scholar 

Chen D, Liu W, Leng E, et al. Effect of splenectomy on CCl4-induced liver fibrosis in rats. Chin Med J (Engl). 1998;111:779–83.

CAS  PubMed  Google Scholar 

Morinaga A, Ogata T, Kage M, et al. Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model. HPB (Oxford). 2010;12:22–30.

Article  PubMed  Google Scholar 

Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol. 2002;17:59–65.

Article  CAS  PubMed  Google Scholar 

Ueda S, Yamanoi A, Hishikawa Y, et al. Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab Invest. 2003;83:1595–603.

Article  CAS  PubMed  Google Scholar 

Arakawa Y, Shimada M, Uchiyama H, et al. Beneficial effects of splenectomy on massive hepatectomy model in rats. Hepatol Res. 2009;39:391–7.

Article  PubMed  Google Scholar 

Ugel S, Peranzoni E, Desantis G, et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep. 2012;2:628–39.

Article  CAS  PubMed  Google Scholar 

Aoe T, Okamoto Y, Saito T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med. 1995;181:1881–6.

Article  CAS  PubMed  Google Scholar 

Shimada M, Hashizume M, Shirabe K, et al. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc. 2000;14:127–30.

Article  CAS  PubMed  Google Scholar 

Karakantza M, Mouzaki A, Theodoropoulou M, et al. Th1 and Th2 cytokines in a patient with Evans’ syndrome and profound lymphopenia. Br J Haematol. 2000;110:968–70.

Article  CAS  PubMed  Google Scholar 

Nomura Y, Kage M, Ogata T, et al. Influence of splenectomy in patients with liver cirrhosis and hypersplenism. Hepatol Res. 2014;44:E100–9.

Article  CAS  PubMed  Google Scholar 

Hashimoto N, Shimoda S, Kawanaka H, et al. Modulation of CD4+ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol. 2011;165:243–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voutsadakis IA. PD-1 inhibitors monotherapy in hepatocellular carcinoma: meta-analysis and systematic review. Hepatobiliary Pancreat Dis Int. 2019;18:505–10.

Article  PubMed  Google Scholar 

Voutsadakis IA. Immune ligands for cytotoxic T lymphocytes (CTLS) in cancer stem cells (CSCS). Front Biosci (Landmark Ed). 2018;23:563–83.

Article  CAS  PubMed  Google Scholar 

Han Y, Liu Q, Hou J, et al. Tumor-induced generation of splenicerythroblast-like ter-cells promotes tumor progression. Cell. 2018;173:634-48.e612.

Article  CAS  PubMed  Google Scholar 

Shi H, Han X, Sun Y, et al. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells. Cancer Sci. 2018;109:3826–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian-Jiao Li, Hao Li, Zhang W-H, et al. Human splenic TER cells: a relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma. Int J Cancer. 2021;148:1756–67.

Article  Google Scholar 

Jiang GQ, Chen P, Qian JJ, et al. Perioperative advantages of modified laparoscopic vs open splenectomy and azygoportal disconnection. World J Gastroenterol. 2014;20:9146–53.

PubMed  PubMed Central  Google Scholar 

Jiang XZ, Zhao SY, Luo H, et al. Laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension. World J Gastroenterol. 2009;15:3421–5.

Article  PubMed  PubMed Central  Google Scholar 

Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res. 1999;85:51–61.

Article  CAS  PubMed  Google Scholar 

Sklar LS, Anisman H. Stress and coping factors influence tumor growth. Science. 1979;205:513–5.

Article  CAS  PubMed  Google Scholar 

Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress on cancer metastasis. Future Oncol. 2010;6:1863–81.

Article  PubMed  Google Scholar